Form 4: Viemed Healthcare Executive Reports Stock Transactions Following Vesting

Sentiment:

SEC Form 4 Filing


A Viemed Healthcare executive, Jerome Cambre, reported the vesting of restricted stock units and phantom share units, along with associated tax withholdings and share transactions.

Summary

  • Jerome Cambre, Vice President of Sales at Viemed Healthcare, reported several transactions involving the company's stock on January 29, 2025.
  • These transactions include the vesting of 8,619 restricted stock units (RSUs) and 2,873 phantom share units.
  • A total of 2,582 shares were withheld to cover tax obligations related to the vesting of the RSUs.
  • The vesting of phantom shares resulted in the acquisition of 2,873 common shares and a simultaneous disposition of the same number of shares for cash.
  • The price per share for the tax withholding and phantom share transactions was $8.28, based on the market closing price on January 29, 2025.
  • Following these transactions, Cambre beneficially owns 89,071 common shares directly.

Sentiment

Score: 7

Explanation: The document reflects routine executive compensation transactions, which are neither positive nor negative for the company's overall performance. The sentiment is neutral to slightly positive as it indicates the executive is receiving compensation.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the vesting schedule of equity-based compensation.

Comparison to Industry Standards

  • The vesting schedule of three equal annual installments is a common practice for equity compensation in the industry.
  • The use of both restricted stock units and phantom share units is also a typical approach for aligning executive interests with shareholder value.
  • The tax withholding process is standard practice for equity compensation.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
  • The transactions do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
01/29/2024Date of grant for the restricted stock units and phantom share units.
01/29/2025Date of vesting and transactions for restricted stock units and phantom share units.
01/29/2027Expiration date for the restricted stock units and phantom share units.
01/31/2025Date the Form 4 was signed.

Keywords

Viemed Healthcare, stock transactions, restricted stock units, phantom share units, insider trading, executive compensation, Form 4, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.